Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer Sees Asia Pacific As Biggest Sales Growth Potential

This article was originally published in PharmAsia News

Executive Summary

Bayer Schering Pharma is looking to the Asia Pacific region for sales growth in the next few years in the high double digits. Already, the region accounts for more than 9 percent of the company's global sales this year. The head of the region's unit of Germany's Bayer AG said Asia Pacific was the main region of growth for Bayer Schering Parma in 2007, increasing by more than 26 percent. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel